Early metabolic risk evaluation and preventive measures at antiretroviral therapy initiation are critical for managing age-related comorbidities in people with HIV.
Infectious Disease Advisor news story
Among people with HIV, obesity at the start of antiretroviral therapy (ART) may be associated with poorer long-term outcomes, with the association potentially more pronounced among younger adults, according to study findings published in eClinicalMedicine.
Researchers conducted a prospective cohort study using data from the Italian Cohort Naive Antiretrovirals Foundation Study. The analysis included ART-naive adults receiving care across 96 sites in Italy who were enrolled between January 1997 and July 2025. Eligible participants had a BMI greater than 18.5 kg/m² and no history of AIDS, cardiovascular disease, or cancer when they began ART.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.